Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure X… Read more
Market Cap & Net Worth: Emcure Pharmaceuticals Ltd (EMCURE)
Emcure Pharmaceuticals Ltd (NSE:EMCURE) has a market capitalization of $3.19 Billion (₹276.47 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #9233 globally and #373 in its home market, demonstrating a 3.01% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Emcure Pharmaceuticals Ltd's stock price ₹1458.40 by its total outstanding shares 189572547 (189.57 Million).
Emcure Pharmaceuticals Ltd Market Cap History: 2024 to 2026
Emcure Pharmaceuticals Ltd's market capitalization history from 2024 to 2026. Data shows growth from $3.17 Billion to $3.30 Billion (24.47% CAGR).
Index Memberships
Emcure Pharmaceuticals Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$1.33 Trillion | 0.05% | #320 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$188.43 Billion | 0.33% | #109 of 250 |
Weight: Emcure Pharmaceuticals Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Emcure Pharmaceuticals Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Emcure Pharmaceuticals Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Emcure Pharmaceuticals Ltd's market cap is 0.04 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.44x
Emcure Pharmaceuticals Ltd's market cap is 0.44 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $3.17 Billion | $66.58 Billion | $4.98 Billion | 0.05x | 0.64x |
| 2025 | $2.99 Billion | $78.08 Billion | $6.81 Billion | 0.04x | 0.44x |
Competitor Companies of EMCURE by Market Capitalization
Companies near Emcure Pharmaceuticals Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Emcure Pharmaceuticals Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Emcure Pharmaceuticals Ltd Historical Marketcap From 2024 to 2026
Between 2024 and today, Emcure Pharmaceuticals Ltd's market cap moved from $3.17 Billion to $ 3.30 Billion, with a yearly change of 24.47%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹3.30 Billion | +10.33% |
| 2025 | ₹2.99 Billion | -5.71% |
| 2024 | ₹3.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Emcure Pharmaceuticals Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.19 Billion USD |
| MoneyControl | $3.19 Billion USD |
| MarketWatch | $3.19 Billion USD |
| marketcap.company | $3.19 Billion USD |
| Reuters | $3.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.